Agilon Health (AGL) closed at $113.52 on November 10, 2026, down 0.4% from the previous close, on volume of 139,921 shares (30-day average 212,266).
Data as of November 10, 2026.
| # | Date | Strategy | Legs | Contracts |
|---|---|---|---|---|
| 1 | Oct 26, 2026 | Put with Delta Hedge | 20-Nov-26 85 P +1,920 Stock | 200 |
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 9, 2026. See the 10 largest for 30, 60 and 90 days
Agilon Health Earnings Call Signals Stronger Profits, Growth
TipRanks (Sat, 7-Nov 7:27 PM ET)
Business Wire (Thu, 5-Nov 7:30 AM ET)
Agilon Health (AGL) Gets a Hold from Barclays
TipRanks (Thu, 5-Nov 3:41 AM ET)
agilon health Reports Third Quarter 2026 Results
Business Wire (Wed, 4-Nov 4:05 PM ET)
agilon health Sets Date to Report Third Quarter 2026 Financial Results
Business Wire (Mon, 5-Oct 4:05 PM ET)
agilon health and The Jackson Clinic Advance Their Partnership Through Senior Health Connect ACO
Business Wire (Wed, 30-Sep 9:00 AM ET)
Market Chameleon (Thu, 24-Sep 7:51 AM ET)
agilon health and Springfield Clinic Broaden Partnership Through Senior Health Connect ACO
Business Wire (Wed, 23-Sep 9:00 AM ET)
agilon health and Family Practice Center Expand Relationship Through Senior Health Connect ACO
Business Wire (Thu, 10-Sep 9:00 AM ET)
Business Wire (Thu, 27-Aug 4:05 PM ET)
Agilon Health Inc is a healthcare services company that partners with primary care physicians to support value-based care for senior patients. The company provides a platform that enables physician groups to manage healthcare outcomes and costs through a Medicare-centric, capitated care model and long-term partnerships with community-based physicians.
Agilon Health trades on the NYSE stock market under the symbol AGL.
As of November 10, 2026, AGL stock price declined to $113.52 with 139,921 million shares trading.
AGL has a beta of 4.65, meaning it tends to be more sensitive to market movements. AGL has a correlation of 0.14 to the broad based SPY ETF.
AGL has a market cap of $1.89 billion. This is considered a Small Cap stock.
Last quarter Agilon Health reported $2 billion in Revenue and $1.97 earnings per share. This beat revenue expectation by $60 million and exceeded earnings estimates by $2.96.
In the last 3 years, AGL traded as high as $344.00 and as low as $7.48.
The top ETF exchange traded funds that AGL belongs to (by Net Assets): IWM, VTI, FNDA, IWO, FYC.
AGL has outperformed the market in the last year with a price return of +580.6% while the SPY ETF gained +12.9%. AGL has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +18.9% and +25.7%, respectively, while the SPY returned -2.8% and -2.0%, respectively.
AGL support price is $109.58 and resistance is $118.46 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AGL shares will trade within this expected range on the day.
